DMD and intrahepatic cholangiocarcinoma: We confirmed this by co-probing the myoblasts for two centrosomal marker proteins, which resulted in staining patterns characterized by widely overlapping immunosignals corresponding to dystrophin and γ-tubulin (Figs 1A and B and S1A and B and Video 1; secondary antibody controls for ICC experiments are shown in Fig S1C) or centrin-1 (Fig S1D).